English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

Identification of a class of non-conventional ER-stress-response-derived immunogenic peptides

MPS-Authors
/persons/resource/persons208298

Liepe,  J.
Research Group of Quantitative and System Biology, MPI for Biophysical Chemistry, Max Planck Society;

External Resource
No external resources are shared
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)

3356810.pdf
(Publisher version), 4MB

Supplementary Material (public)
There is no public supplementary material available
Citation

Melacarne, A., Ferrari, V., Tiraboschi, L., Mishto, M., Liepe, J., Aralla, M., et al. (2021). Identification of a class of non-conventional ER-stress-response-derived immunogenic peptides. Cell Reports, 36(1): 109312. doi:10.1016/j.celrep.2021.109312.


Cite as: https://hdl.handle.net/21.11116/0000-0009-96F2-C
Abstract
Efforts to overcome resistance to immune checkpoint blockade therapy have focused on vaccination strategies using neoepitopes, although they cannot be applied on a large scale due to the “private” nature of cancer mutations. Here, we show that infection of tumor cells with Salmonella induces the opening of membrane hemichannels and the extracellular release of proteasome-generated peptides by the exacerbation of endoplasmic reticulum (ER) stress. Peptides released by cancer cells foster an antitumor response in vivo, both in mice bearing B16F10 melanomas and in dogs suffering from osteosarcoma. Mass spectrometry analysis on the supernatant of human melanoma cells revealed 12 peptides capable of priming healthy-donor CD8+ T cells that recognize and kill human melanoma cells in vitro and when xenotransplanted in vivo. Hence, we identified a class of shared tumor antigens that are generated in ER-stressed cells, such as tumor cells, that do not induce tolerance and are not presented by healthy cells.